腕管松解术后PROMIS与QuickDASH的最小临床重要差值是多少?一项前瞻性队列研究
该前瞻性队列研究纳入147例接受单侧腕管松解术的成人患者,最终分析122例(应答比例83%),于术前和术后3个月收集PROMIS上肢、PROMIS疼痛干扰和QuickDASH评分,并采用锚定法和分布法计算最小临床重要差值(MCID)。最终提出的MCID值为PROMIS上肢6.2、PROMIS疼痛干扰-7.8、QuickDASH -18.2;作者推荐临床使用6、-8和-18。
要点
- 最终提出的MCID值为PROMIS上肢6.2、PROMIS疼痛干扰-7.8、QuickDASH -18.2。
- 作者推荐临床采用PROMIS上肢6、PROMIS疼痛干扰-8、QuickDASH -18作为MCID。
- 研究为前瞻性队列,最终分析122例,应答比例83%(122/147)。
核心结论
- 作者推荐临床医生将PROMIS上肢6、PROMIS疼痛干扰-8和QuickDASH -18作为腕管松解术后的MCID值。
- 作者认为外科医生在术后向患者说明改善情况时可能觉得这些值有用。
- 未来研究可探讨PROMIS工具单一MCID(或小范围)是否适用于多种疾病和干预。
研究设计与样本
- 研究为在城市、中西部、多医院学术卫生系统开展的前瞻性队列研究。
- 2020年9月至2022年2月识别147例接受单侧腕管松解术的成人患者,排除未回复术后3个月问卷者,最终分析122例(应答比例83%,122/147)。
- 患者平均年龄57岁(范围23至87岁),68%为女性。
- 术前和术后3个月收集PROMIS上肢、PROMIS疼痛干扰和QuickDASH评分,并收集锚定问题「自治疗以来,您如何评价整体功能?」的应答(选项:差很多、差、稍差、无变化、稍改善、改善、改善很多)。
- MCID采用锚定法和分布法计算,并确定MCID值范围以提出三种工具的最终MCID值。
主要发现
- 最终提出的MCID值为PROMIS上肢6.2(四分位距5.4至9.0)。
- 最终提出的MCID值为PROMIS疼痛干扰-7.8(四分位距-6.1至-8.5)。
- 最终提出的MCID值为QuickDASH -18.2(四分位距-13.3至-34.1)。
- PROMIS疼痛干扰的负值代表疼痛减轻,PROMIS上肢的正值代表功能改善,QuickDASH的负值代表功能增加。
关键数值与推荐
- 最终提出的MCID值:PROMIS上肢6.2(四分位距5.4至9.0)、PROMIS疼痛干扰-7.8(四分位距-6.1至-8.5)、QuickDASH -18.2(四分位距-13.3至-34.1)。
- 作者推荐临床使用的MCID值:PROMIS上肢6、PROMIS疼痛干扰-8、QuickDASH -18。
- 证据等级为II级,治疗性研究。
临床怎么用
- 作者推荐临床医生使用PROMIS上肢6、PROMIS疼痛干扰-8和QuickDASH -18作为腕管松解术后的MCID值。
- 作者认为外科医生在术后向患者说明改善情况时可能觉得这些值有用。
局限性
- 既往确定腕管松解术后MCID的尝试受方法学问题限制,包括缺乏真正的锚定法MCID计算。
- 未来研究可探讨PROMIS工具单一MCID(或小范围)是否适用于多种疾病和干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To better define the clinical significance of patient-reported outcomes, the concept of a minimum clinically important difference (MCID) exists. The MCID is the minimum change that a patient will perceive as meaningful. Prior attempts to determine the MCID after carpal tunnel release are limited by methodologic concerns, including the lack of a true anchor-based MCID calculation. QUESTIONS/PURPOSES: To address previous methodologic concerns in existing studies, as well as establish a clinically useful value for clinicians, we asked: What are the MCID values for the Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity (UE), PROMIS Pain Interference (PI), and the QuickDASH after carpal tunnel release? METHODS: We conducted a prospective cohort study at an urban, Midwest, multihospital, academic health system. One hundred forty-seven adult patients undergoing unilateral carpal tunnel release between September 2020 and February 2022 were identified. PROMIS UE, PI, and QuickDASH scores were collected preoperatively and 3 months postoperatively. We also collected responses to an anchor-based question: "Since your treatment, how would you rate your overall function?" (much worse, worse, slightly worse, no change, slightly improved, improved, or much improved). Patients who did not respond to the 3-month postoperative surveys were excluded. A total of 122 patients were included in the final analysis (83% response proportion [122 of 147]). The mean age was 57 years (range 23 to 87 years), and 68% were women. The MCID was calculated using both anchor-based and distribution-based methods. Although anchor-based calculations are generally considered more clinically relevant because they consider patients' perceptions of improvement, an estimation of the minimum detectable change (which represents measurement error) relies on a distribution-based calculation. We determined a range of MCID values to propose a final MCID value for all three instruments. A negative MCID value for the PROMIS PI instrument represents a decrease in pain, whereas a positive value for the PROMIS UE instrument represents an improvement in function. A negative value for the QuickDASH instrument represents an increase in function. RESULTS: The final proposed MCID values were 6.2 (interquartile range [IQR] 5.4 to 9.0) for the PROMIS UE, -7.8 (IQR -6.1 to -8.5) for the PROMIS PI, and -18.2 (IQR -13.3 to -34.1) for the QuickDASH. CONCLUSION: We recommend that clinicians use the following values as the MCID after carpal tunnel release: 6 for the UE, -8 for the PI, and -18 for the QuickDASH. Surgeons may find these values useful when counseling patients postoperatively regarding improvement. Future studies could examine whether a single MCID (or small range) for PROMIS instruments is applicable to a variety of conditions and interventions. LEVEL OF EVIDENCE: Level II, therapeutic study.
引用
- Jiang EX, Tang X, Korn MA, et al. What are the Minimum Clinically Important Difference Values for the PROMIS and QuickDASH After Carpal Tunnel Release? A Prospective Cohort Study. Clin Orthop Relat Res. 2022. PMID: 36190518. doi:10.1097/CORR.0000000000002437
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。